Specifically designed for clinical oncologists, registered nurses, nurse practitioners, and the entire medical team involved in treating cancer patients with immunotherapy, these introductory, CME- and CNE-certified programme will provide an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field.

Presented by leading authorities in tumour immunology and cancer immunotherapy, this programme will facilitate understanding of 1) the underlying principles of tumour immunology and immunotherapy, 2) the clinical indications for cancer immunotherapy and appropriate selection of patients, 3) patient management, and 4) the therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes.

Attendees can also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange with experts, clinical oncologists and other health care providers from the surrounding community.

The target audience for these programmes includes clinical oncologists, registered nurses, nurse practitioners, the entire medical team involved in patient care, early career individuals, allied health professionals, and patient advocates who wish to learn principles of tumour immunology and immunotherapy, as well as improve their ability to select patients for immunotherapy and provide state-of-the-art clinical management for their patients.

Session Topics

• Immunology 101 for the Non-Immunologist
• Basic Principles of Tumour Immunotherapy
• Basic Mechanisms of Tumour Immune Suppression
• Cytokines: Interferons, Interleukins and Beyond
• Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies
• Active Immunisation Approaches
• Current Status of Chimeric and Adoptive T Cell Therapy
• Is There a Role for Radiation Therapy and Immunotherapy?
• Immune-Related Adverse Events
• Immunotherapy for the Treatment of:
• Melanoma
• GU Malignancies
• Non-Small Cell Lung Carcinoma
• Haematologic Malignancies
• Brain Metastases